Colchicine After Electrocardioversion for Atrial Fibrillation
Status:
Not yet recruiting
Trial end date:
2025-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate whether a 3 month treatment course of low-dose
Colchicine decreases the recurrence of Atrial fibrillation (AF) after electrocardioversion
(ECV) in patients with AF.
Phase:
Phase 3
Details
Lead Sponsor:
University Hospital, Basel, Switzerland
Collaborators:
Fondation Machaon, Switzerland, Genf Foundation for Cardiovascular Research Basel Swiss Heart Foundation